Aim: To describe clinical manifestations, angiographic findings, treatment, activity and damage of our Takayasu arteritis patients.
American studies. 4 Delay in diagnosis and treatment is a common challenge owing to the high frequency of nonspecific systemic features. When the diagnosis is established, vascular involvement is frequently at the irreversible stage. 1 Childhood-onset Takayasu arteritis is reported to be a more refractory disease with lower rates of remissions compared to adult counterparts. 5 Assessment of disease activity and treatment response is still the most difficult challenge for clinicians. [6] [7] [8] There are limited data on clinical features, assessment of disease activity and long-term outcome of Takayasu arteritis in children. Furthermore, there are unmet medical needs in evaluation of the efficacy of current therapies, since the spectrum of treatment options have been increased compared to the past.
We aimed to report our referral center experience on the clinical features and treatment options of Takayasu arteritis. In addition, we have evaluated the correlation of various activity and damage scores with each other.
| ME THODS

| Enrolment process and ethical approval
We performed a retrospective chart review for Takayasu arteritis between January 2002 and January 2017 at our tertiary referral pediatric rheumatology center. In addition to the cases that are cur- 
| Data collection: Demographic and clinical features with laboratory findings
Demographic data, including age at disease onset and at diagnosis, gender, duration of disease and baseline clinical manifestations were noted.
Arterial hypertension was defined as blood pressure >95th percentile for age. Presence of a blood pressure difference more than 10 mm Hg between limbs was defined as a blood pressure discrepancy. Laboratory results included erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) both at baseline and at last follow-up visit. ESR more than 20 mm/h and CRP level more than 0.5 mg/dL were defined as increased. which is calculated by adding the score for acute phase reactants to the total score of ITAS2010, has not been calculated in this study.
| Activity and damage/outcome assessment
| Angiographic features and classification
Imaging findings of Takayasu arteritis range from arterial wall enhancement and stenosis to occlusion and formation of aneurysms. Moreover, the agreement between PVAS, ITAS2010 and DEI.Tak was estimated by using κ statistics (unweighted κ for dichotomous assessment). Categorical variables were expresses as numbers and percentages. A P value <0.05 was considered statistically significant. 
| RE SULTS
| Demographic and clinical data
| Angiographic involvement patterns
The most common angiographic involvement type according to the Numano classification system was type IV seen in five patients, followed by type V in 4, type III and II in three patients each and type I in one patient.
When compared with less extensive angiographic patterns (type I-II-III-IV), patients with type V disease had significantly lower hemoglobin levels and higher ESR (P < 0.05; Table 2 ). Although the high leucocyte count, high CRP levels and thrombocytosis were more prominent in type V disease, this was not statistically significant
The most common pattern of vascular abnormality in angiography was stenosis (53.5% of all lesions) followed by arterial wall enhancement (30.3%), occlusion (11.1%) and aneurysm (5.1%). The percentage of patients with any pattern of vascular involvement according to anatomic location were: 75% (n = 12) abdominal aorta, 68.8% thoracic aorta (n = 11), 68.8% superior mesenteric artery (n = 11) and 62% renal arteries (n = 10). The least frequently affected primary branch of the aorta was the iliac artery (n = 4, 25%).
Among the patients who underwent repeat angiography (n = 12), new areas of vascular involvement were observed in four subjects.
The median time interval between the first and last angiography was 9.4 years (range 9 months to 14 years).
| Correlations between disease activity indices
Subjects had extensive disease at presentation with a median DEI.
Tak score of 14 (range 3-24, IQR 9.3-17.5). All of the subjects had elevated acute-phase reactants and were active at presentation 
TA B L E 1 Clinical and laboratory features of Takayasu arteritis patients
Clinical manifestations and findings at baseline n (%) While all subjects were active (score ≥1) at baseline, 6/16 subjects were inactive (score = 0) at last evaluation according to the three activity tools. The subjects were categorized into two groups according to the three activity indices at last follow-up visit: active (score ≥1) or inactive (score = 0). The total agreement between PVAS and DEI.Tak (87.5%, κ = 0.73) was the highest among the indices.
Additionally, ITAS2010 showed moderate agreement with PVAS (75%, κ = 0.52) and DEI.Tak (75%, κ = 0.51).
ITAS2010 was the only activity index that has been found to significantly correlate with ESR both at disease onset (r = 0.6, P = 0.015) and at last visit (r = 0.52, P = 0.037). In contrast, neither DEI.Tak nor PVAS correlated with ESR both at disease onset and at follow-up (P > 0.05).
| Treatment
The most frequently used immunosuppressive drugs in therapy were corticosteroids (n = 16/16, 100%), followed by azathioprine (n = 15/16, 93.8%), cyclophosphamide (n = 10/16, 62.5%), methotrexate (n = 6/16, 37.5%) and tocilizumab (n = 6/16, 37.5%). The rate of interventional procedure either endovascular and/or bypass was not rare (n = 7/16, 43.8%). Six of the 16 subjects (37.5%) underwent percutaneous transluminal angioplasty (PTA) procedure, whereas bypass surgery was required in two patients.
| Damage and outcome
The PVDI score at last visit was 4 (range 1-7), whereas the median of the last TADS was 9 (range 0-17). TADS correlated highly significantly with PVDI score (r = 0.85, P < 0.001). We found a significant correlation of PVDI with PVAS (r = 0.81, P < 0.001), DEI. Tak (r = 0.64, P < 0.01) and ITAS2010 (r = 0.55, P < 0.05) scores at disease onset, whereas no correlation could be seen with acute phase markers (CRP and ESR), age at disease onset and at diagnosis, duration of disease and duration of the delay in diagnosis (P > 0.05). In addition, PVDI did not correlate with any of the activity indices that were measured at last visit P > 0.05).
Despite the high frequency of surgical procedures, there was no deceased patient with Takayasu arteritis in the last 15 years.
| D ISCUSS I ON
In this study, we have reviewed the clinical and imaging features of children with Takayasu arteritis in a single center. We have also studied the correlations of various activity indices with different variables and evaluated outcome by mortality rate and damage indices. Moreover, this study provides comparison of clinical characteristics, treatment options and outcome with previous pediatric cohorts (Table 3 ).
| Demographic features
Female preponderance (75%) was in line with previous reports which documented the female frequency between 64% and 79%.
5,21-28
Establishment of the diagnosis of Takayasu arteritis took a median of 2.5 months in our cohort, which was quite shorter compared to a previous Turkish cohort (median 12 months), and also compared to many previous reports.
| Clinical manifestations
Constitutional findings along with headache and musculoskeletal manifestations are the most common presenting complaints in different studies from various countries. The frequency of these nonspecific systemic features in children with Takayasu arteritis was reported to be twice of that in adult-onset Takayasu arteritis. 2, 5 Similar to previous reports, constitutional symptoms were the most common complaints, accounting for 81.2% of our cohort. The most common physical examination finding in many studies is hypertension followed by blood pressure discrepancy or bruits.
5,21-25,27,28
The most frequently detected abnormal findings at first admission in descending order were bruits (87.5%), blood pressure discrepancy (75%), decreased/absent pulse (75%) and systemic hypertension (62.5%). Raised inflammatory markers, either CRP or ESR, were found in all of our subjects at baseline. In view of these findings, coexistence of vague constitutional manifestations and repeated increase in acute phase markers particularly in adolescent females, should alert the physician to the possibility of Takayasu arteritis.
| Angiography
Type V and type IV are unequivocally the most frequently reported angiographic involvement patterns in previously published studies regarding childhood-onset Takayasu arteritis. 1,4,5,7-9 Similar to other case series, in our study the most common type of involvement pattern was type IV followed by type V with respect to Numano's angiographic classification. Only a study from China documented type III as the most frequently seen pattern in children. 27 Accordingly, in our cohort when segments and branches of the aorta were assessed individually, abdominal aorta was the most frequently affected part, followed by thoracic aorta, similar to a USA study. 23 Abdominal aorta and renal artery are the most involved vessels in the majority of the aforementioned studies. 21, 25, 26, 28 Additionally, we found a higher frequency of left renal artery stenosis (50%) compared to the right (31.2%), which is in line with the rates reported by previous studies. 5, 29, 30 Overall frequency of renal artery involvement was 75% in our cohort (62.5% in left vs 50% in right renal artery).
Further, a Brazilian comparison study reported a higher frequency of renal artery stenosis in pediatric subjects compared to an adult cohort (47% vs 28.9%). a median of 0, 1 and 0 at last visits, respectively. Further, we have confirmed the good correlation and concordance between the three activity indices (ITAS2010, PVAS and DEI.Tak) in juvenile Takayasu arteritis, as previously described.
22,28
| Outcome and damage
Although frequently recognized in Asian populations, Takayasu arteritis is seen worldwide. In our cohort, there was no patient in the last 15 years, who died as a result of Takayasu arteritis and related complications. The mortality rate was between 22.55%-35% in the surveys before 2000, 2,29,31 which decreased below 15% in reports that have been published during the past decade. 5, 21, [24] [25] [26] 32, 33 In a South African study, the deaths were as a result of uncontrolled systemic hypertension and complications related to surgery. 29 Retrospective cohort studies, which document no deceased patient, are currently not rare. 23, 27, 28 In the last 10 years, only in a UK cohort was the mortality rate (27%) relatively high compared to other studies. 22 The authors acknowledged the referral bias as an underlying factor for this severe spectrum and poor outcome.
Despite the fairly good control of disease activity in our subjects, accrual of significant damage could not have been precluded (median TADS and PVDI: 9 and 4, respectively). There was a good correlation of PVDI with TADS score in our study. Damage calculated by the PVDI index best correlated with baseline PVAS, followed by baseline DEI.
Tak and ITAS2010. However, neither the age at disease onset nor the acute phase markers at disease onset (ESR and CRP) affected the damage score. In an Indian paper, delay in diagnosis resulted in progression of disease and major damage. 25 However, we could not find an association between damage and diagnostic delay and disease duration.
To date, only one study from Turkey described the clinical manifestations and outcome of childhood-onset Takayasu arteritis. In this historical cohort, there were 19 patients from nine centers. multicentric cohort compared to our study (52.6% vs 43.8%). While 21.1% (n = 4) of the previous cohort needed bypass surgery, this rate was only 12.5% (n = 2) in our cohort. In addition, two subjects underwent unilateral nephrectomy due to atrophy as a consequence of uncontrolled renal artery stenosis and a renal autotransplantation was performed in another subject. 21 In our group, there was no such case that underwent such a complication-related major surgical procedure.
| Treatment
Aggressive and long-term immunosuppression is mandatory to decrease or at least to stabilize disease activity within mild or moderate whereas only in an Indian study mycophenolate mofetil was the second most commonly used agent. 25 However, in our cohort it was obvious that azathioprine was the most commonly preferred agent after corticosteroids.
About one-quarter of the subjects seem unresponsive to the conventional therapies. 2, 36 Biologic therapies, predominantly antitumor necrosis factor alpha and anti-interleukin-6 agents, may have beneficial effects in these particular subjects; however, there has been no randomized therapeutic trial in Takayasu arteritis. 2, 32, [37] [38] [39] [40] [41] [42] [43] [44] [45] Tocilizumab, which has been used in six out of 17 subjects, was the only preferred biologic agent in our clinic. Among pediatric cohort studies, high rate of biologic agent treatment was only remarkable in the British and US pediatric Takayasu cohort. 22, 23 In contrast, tocilizumab is a widely used biologic drug in adult-onset refractory Takayasu arteritis patients and it has been shown to be effective in reduction of steroid dosage and disease activity. 39, 41, 43, 44, 46 Tocilizumab eliminated the requirement of intravascular intervention in three Colombian Takayasu arteritis patients. 46 However, in an
Italian report, four of the seven refractory Takayasu arteritis patient showed radiological vascular progression on tocilizumab. 47 Future randomized controlled studies are warranted to confirm these preliminary observations.
Satisfactory long-term results have been achieved after a 20-year period in refractory Takayasu arteritis children who had been undergone surgical or percutaneous procedures. 48 Only two patients in our cohort required bypass surgery.
| LIMITATI ON S AND CON CLUS I ON
The main limitations of our study are its retrospective nature and small sample size. Furthermore, there is an increased risk in recruiting the patients, which are at the more severe end of the disease spectrum, because of the referral bias.
To our knowledge this study is the largest cohort of Turkish pediatric Takayasu arteritis patients that has been done after a multicentric survey in 2008. 21 Three different disease activity scores and two damage scores were in great concordance with each other.
The only predictor of the damage were the extent and activity of the disease at baseline. There has been no deceased Takayasu patient in the last 15 years. Fairly good clinical outcomes compared to the past may be due to new biologic drugs and/or improved surgical techniques. Early diagnosis and advanced multidisciplinary therapy seem to result in a favorable disease outcome, namely in survival rates and the reduced need for complicated surgeries.
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